Skip to main content
. 2023 May 22;22(2):1159–1165. doi: 10.1007/s40200-023-01226-0

Table 2.

Fasting plasma glucose and serum 25-hydroxy vitamin D levels of study participants (N = 510)

Outcomes Study Participants P-value
All Swedish Descent a Middle Eastern Descent b
Total, n (%) 510 (100) 278 (100) 232 (100) -
Fasting plasma glucose level, mean (SD), mmol/L 5.7 (0.8) 5.7 (0.5) 5.6 (0.5) 0.03d
Abnormal (> 6.0 mmol/L) fasting plasma glucose, n (%) 196 (38.4) 101 (36.3) 95 (40.9) 0.29c
s-25(OH)D level, median (IQR), nmol/L 46 (28–68) 62 (50–86) 34 (21–47) < 0.001e

Inadequate (≤ 50 nmol/L)

s-25(OH)D, n (%)

213 (41.8) 57 (20.5) 156 (67.2) < 0.001c

Deficiency (< 30 nmol/L)

s-25(OH)D, n (%)

100 (19.6) 14 (5.0) 86 (37.1) < 0.0001c

a Born in Sweden to parents born in Sweden

b Born in or one parent born in Turkey, Iran, or Iraq [including region of Kurdistan]

c Based on the chi-square test

d Based on t-test

e Based on Wilcoxon rank sum test

Abbreviations: SD, standard deviation; s-25(OH)D, serum 25-hydroxy vitamin D; IQR, interquartile range